Literature DB >> 8393425

Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.

S Schneider1, G Wildhardt, R Ludwig, B Royer-Pokora.   

Abstract

A germline WT-1 point mutation is described in a patient with unilateral Wilms' tumor, nephritis and ambiguous external genitalia. The patient was diagnosed as a possible case of Denys Drash syndrome (DDS). Analysis of the WT-1 exons and intron borders revealed a G to C transversion in the +1 position of the splice donor consensus sequence in intron 6. Two transcripts of abnormal size were identified in tumor RNA. Sequencing of the altered WT-1 mRNA revealed that this point mutation leads to exon-skipping, resulting in transcripts either missing exon 6 or exons 5 and 6. The normally occurring alternative splicing of exon 5 in the WT-1 gene is not affected by this mutation. The reading frame is changed when either both exons 5 and 6 or exon 6 alone are missing and a stop codon follows immediately downstream in exon 7. Most mutations identified in DDS are missense mutations located in the zinc finger (ZF) region (exons 7, 8 and 9) but recently a patient with a germline mutation in exon 6 leading to premature chain termination was described. Therefore the site of the mutation in the WT-1 gene in this patient cannot exclude the possibility that he has DDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393425     DOI: 10.1007/bf00205087

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.

Authors:  B Brenner; G Wildhardt; S Schneider; B Royer-Pokora
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

2.  Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare.

Authors:  B Royer-Pokora; S Ragg; B Heckl-Ostreicher; M Held; U Loos; K Call; T Glaser; D Housman; G Saunders; B Zabel
Journal:  Genes Chromosomes Cancer       Date:  1991-03       Impact factor: 5.006

3.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

4.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion--report of 10 cases.

Authors:  R Habib; C Loirat; M C Gubler; P Niaudet; A Bensman; M Levy; M Broyer
Journal:  Clin Nephrol       Date:  1985-12       Impact factor: 0.975

6.  Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome).

Authors:  L Jadresic; J Leake; I Gordon; M J Dillon; D B Grant; J Pritchard; R A Risdon; T M Barratt
Journal:  J Pediatr       Date:  1990-11       Impact factor: 4.406

7.  Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT.

Authors:  V Huff; H Miwa; D A Haber; K M Call; D Housman; L C Strong; G F Saunders
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

8.  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

Authors:  P N Baird; A Santos; N Groves; L Jadresic; J K Cowell
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

9.  Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE.

Authors:  B Royer-Pokora; S Schneider
Journal:  Genes Chromosomes Cancer       Date:  1992-09       Impact factor: 5.006

10.  A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism.

Authors:  D B Parkinson; R V Thakker
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

View more
  6 in total

1.  Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia.

Authors:  F E Abidi; L Holloway; C A Moore; D D Weaver; R J Simensen; R E Stevenson; R C Rogers; C E Schwartz
Journal:  J Med Genet       Date:  2008-08-12       Impact factor: 6.318

2.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.

Authors:  Kazuhiko Takahara; Ulrike Schwarze; Yasutada Imamura; Guy G Hoffman; Helga Toriello; Lynne T Smith; Peter H Byers; Daniel S Greenspan
Journal:  Am J Hum Genet       Date:  2002-07-17       Impact factor: 11.025

4.  Specific variants in WDR35 cause a distinctive form of Ellis-van Creveld syndrome by disrupting the recruitment of the EvC complex and SMO into the cilium.

Authors:  José A Caparrós-Martín; Alessandro De Luca; François Cartault; Mona Aglan; Samia Temtamy; Ghada A Otaify; Mennat Mehrez; María Valencia; Laura Vázquez; Jean-Luc Alessandri; Julián Nevado; Inmaculada Rueda-Arenas; Karen E Heath; Maria Cristina Digilio; Bruno Dallapiccola; Judith A Goodship; Pleasantine Mill; Pablo Lapunzina; Victor L Ruiz-Perez
Journal:  Hum Mol Genet       Date:  2015-04-23       Impact factor: 6.150

5.  Two-exon skipping within MLPH is associated with coat color dilution in rabbits.

Authors:  Stefanie Lehner; Marion Gähle; Claudia Dierks; Ricarda Stelter; Jonathan Gerber; Ralph Brehm; Ottmar Distl
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 6.  The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.

Authors:  Sven Diederichs; Lorenz Bartsch; Julia C Berkmann; Karin Fröse; Jana Heitmann; Caroline Hoppe; Deetje Iggena; Danny Jazmati; Philipp Karschnia; Miriam Linsenmeier; Thomas Maulhardt; Lino Möhrmann; Johannes Morstein; Stella V Paffenholz; Paula Röpenack; Timo Rückert; Ludger Sandig; Maximilian Schell; Anna Steinmann; Gjendine Voss; Jacqueline Wasmuth; Maria E Weinberger; Ramona Wullenkord
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.